Evaluation of the Early Conversion From a Calcineurin Inhibitor-based Immunosuppressive Regimen to Everolimus in de Novo Renal Transplant Recipients, a Multicenter Experience

Trial Profile

Evaluation of the Early Conversion From a Calcineurin Inhibitor-based Immunosuppressive Regimen to Everolimus in de Novo Renal Transplant Recipients, a Multicenter Experience

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 11 Jun 2013

At a glance

  • Drugs Ciclosporin; Everolimus; Mycophenolate sodium; Steroids; Tacrolimus
  • Indications Transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 14 Mar 2013 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 14 Mar 2013 Planned initiation date changed from 1 Jun 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top